© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Glasgow 2020

Lenacapavir Shows Promise for Long-Acting HIV Treatment and Prevention

A single dose of the HIV capsid inhibitor reduced viral load in highly treatment-experienced people.

Switching to Integrase Inhibitors Not Tied to Gain in “Bad Fat”

A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.

Dovato Posts 3-Year Marks on Par With Tivicay Plus Truvada as HIV Treatment

ViiV’s two-drug Dovato also boasted a high genetic barrier to the development of viral resistance.

Experimental Antiretroviral Has Potential for Once-Weekly HIV Treatment

MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.

Long-Acting Injectable Cabenuva May Not Require Oral Lead-In

A study found no difference in outcomes based on whether participants took oral meds for a month before switching to injectables.

HIV Regimen of Islatravir and Pifeltro Doesn’t Appear to Affect Kidney Function

A mid-stage trial of the experimental drug islatravir plus Pifeltro did not see notable shifts in measures of kidney function.

Switching HIV Treatment to Delstrigo Is Safe and Effective

This is according to a three-year study in which people switched from a stable HIV regimen to Delstrigo.

Islatravir-Based HIV Regimen Fails Few Study Participants

None of the people who experienced virologic failure on regimens containing the experimental drug had a viral load of 200 or higher.
The U.N. General Assembly Hall during the High-level Meeting on HIV/AIDS.

Conferences

Advertisement

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.